Molecular Shape and Medicinal Chemistry: A Perspective

被引:253
作者
Nicholls, Anthony [1 ]
McGaughey, Georgia B. [2 ]
Sheridan, Robert P. [2 ]
Good, Andrew C. [3 ]
Warren, Gregory [1 ]
Mathieu, Magali [4 ]
Muchmore, Steven W. [5 ]
Brown, Scott P. [5 ]
Grant, J. Andrew
Haigh, James A. [1 ]
Nevins, Neysa [6 ]
Jain, Ajay N. [7 ]
Kelley, Brian [1 ]
机构
[1] OpenEye Sci Software Inc, Santa Fe, NM 87508 USA
[2] Merck & Co Inc, Rahway, NJ 07065 USA
[3] Genzyme Corp, Cambridge, MA USA
[4] Sanofi Aventis, Vitry Sur Seine, France
[5] Abbott Labs, Abbott Pk, IL 60064 USA
[6] GlaxoSmithKline, King Of Prussia, PA USA
[7] Univ Calif San Francisco, San Francisco, CA 94143 USA
关键词
EMPIRICAL SCORING FUNCTIONS; FORCE-FIELD; 3-DIMENSIONAL SHAPE; FLEXIBLE LIGANDS; RAPID EVALUATION; DRUG DISCOVERY; SIMILARITY; RECEPTOR; DOCKING; DESIGN;
D O I
10.1021/jm900818s
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The eight contributions here provide ample evidence that shape as a volume or as a surface is a vibrant and useful concept when applied to drug discovery. It provides a reliable scaffold for decoration with chemical intuition (or bias) for virtual screening and lead optimization but also has its unadorned uses, as in library design, ligand fitting, pose prediction, or active site description. Computing power has facilitated this evolution by allowing shape to be handled precisely without the need to reduce down to point descriptors or approximatemetrics, and the diversity of resultant applications argues for this being an important step forward. Certainly, it is encouraging that as computation has enabled our intuition, molecular shape has consistently surprised us in its usefulness and adaptability. The first Aurelius question, What is the essence of a thing?, seems well answered, however, the third, What do molecules do?, only partly so. Are the topics covered here exhaustive, or is there more to come? To date, there has been little published on the use of the volumetric definition of shape described here as a QSAR variable, for instance, in the prediction or classification of activity, although other shape definitions have been successful applied, for instance, as embodied in theCompass programdescribed above in Shape from Surfaces. Crystal packing is a phenomenon much desired to be understood. Although powerful models have been applied to the problem,107 to what degree is this dominated purely by the shape of a molecule? The shape comparison described here is typically of a global nature, and yet some importance must surely be placed on partial shape matching, just as the substructure matching of chemical graphs has proved useful. The approach of using surfaces, as described here, offers some flavor of this, as does the use of metrics that penalize volume mismatch less than the Tanimoto, e.g., Tversky measures. As yet, there is little to go on as to how useful a paradigmthiswill be because there is less software and fewer concrete results.Finally, the distance betweenmolecular shapes, or between any shapes defined as volumes or surfaces, is ametric property in the mathematical sense of the word.As yet, there has been little, if any, application of this observation. We cannot know what new application to the design and discovery of pharmaceuticals may yet arise from the simple concept of molecular shape, but it is fair to say that the progress so far is impressive. © 2010 American Chemical Society.
引用
收藏
页码:3862 / 3886
页数:25
相关论文
共 113 条
[1]  
ANDERSON E, 1987, EPA600M87021 ENV RES
[2]  
AUGUSTUS MAA, 1862, MEDITATIONS, pCH8
[3]  
Ballester PJ, 2007, J COMPUT CHEM, V28, P1711, DOI [10.1002/jcc.20681, 10.1002/JCC.20681]
[4]   Ultrafast shape recognition: Evaluating a new ligand-based virtual screening technology [J].
Ballester, Pedro J. ;
Finn, Paul W. ;
Richards, W. Graham .
JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2009, 27 (07) :836-845
[5]   Hot-spots-guided receptor-based pharmacophores (HS-Pharm): A knowledge-based approach to identify ligand-anchoring atoms in protein cavities and prioritize structure-based pharmacophores [J].
Barillari, Caterina ;
Marcou, Gilles ;
Rognan, Didier .
JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2008, 48 (07) :1396-1410
[6]   Discovery and X-ray Crystallographic Analysis of a Spiropiperidine Iminohydantoin Inhibitor of β-Secretase [J].
Barrow, James C. ;
Stauffer, Shaun R. ;
Rittle, Kenneth E. ;
Ngo, Phung L. ;
Yang, ZhiQiang ;
Selnick, Harold G. ;
Graham, Samuel L. ;
Munshi, Sanjeev ;
McGaughey, Georgia B. ;
Holloway, M. Katharine ;
Simon, Adam J. ;
Price, Eric A. ;
Sankaranarayanan, Sethu ;
Colussi, Dennis ;
Tugusheva, Katherine ;
Lai, Ming-Tain ;
Espeseth, Amy S. ;
Xu, Min ;
Huang, Qian ;
Wolfe, Abigail ;
Pietrak, Beth ;
Zuck, Paul ;
Levorse, Dorothy A. ;
Hazuda, Daria ;
Vacca, Joseph P. .
JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (20) :6259-6262
[7]   2-amino-3,4-dihydroquinazolines as inhibitors of BACE-1 (β-site APP cleaving enzyme):: Use of structure based design to convert a micromolar hit into a nanomolar lead [J].
Baxter, Ellen W. ;
Conway, Kelly A. ;
Kennis, Ludo ;
Bischoff, Francois ;
Mercken, Marc H. ;
De Winter, Hans L. ;
Reynolds, Charles H. ;
Tounge, Brett A. ;
Luo, Chi ;
Scott, Malcolm K. ;
Huang, Yifang ;
Braeken, Mirielle ;
Pieters, Sere M. A. ;
Berthelot, Didier J. C. ;
Masure, Stefan ;
Bruinzeel, Wouter D. ;
Jordan, Alfonzo D. ;
Parker, Michael H. ;
Boyd, Robert E. ;
Qu, Junya ;
Alexander, Richard S. ;
Brenneman, Douglas E. ;
Reitz, Allen B. .
JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (18) :4261-4264
[8]   The properties of known drugs .1. Molecular frameworks [J].
Bemis, GW ;
Murcko, MA .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (15) :2887-2893
[9]   SHOP: Scaffold HOPping by GRID-based similarity searches [J].
Bergmann, Rikke ;
Linusson, Anna ;
Zamora, Ismael .
JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (11) :2708-2717
[10]   The Protein Data Bank [J].
Berman, HM ;
Westbrook, J ;
Feng, Z ;
Gilliland, G ;
Bhat, TN ;
Weissig, H ;
Shindyalov, IN ;
Bourne, PE .
NUCLEIC ACIDS RESEARCH, 2000, 28 (01) :235-242